| 0 |
NATURAL KILLER CELL ACTIVITY ABNORMAL |
1 |
0.1667 |
| 1 |
PUNCTURE SITE PRURITUS |
1 |
0.1250 |
| 2 |
FAT OVERLOAD SYNDROME |
1 |
0.1111 |
| 3 |
DEVICE RELATED FUNGAEMIA |
1 |
0.1000 |
| 4 |
RADIATION OEDEMA |
1 |
0.0909 |
| 5 |
AMEGAKARYOCYTIC THROMBOCYTOPENIA |
1 |
0.0588 |
| 6 |
STOMA SITE COMPLICATION |
1 |
0.0556 |
| 7 |
POSTHAEMORRHAGIC HYDROCEPHALUS |
3 |
0.0517 |
| 8 |
VASCULAR ACCESS SITE OCCLUSION |
4 |
0.0506 |
| 9 |
MUCOSAL PROLAPSE SYNDROME |
1 |
0.0370 |
| 10 |
MECONIUM ILEUS |
2 |
0.0303 |
| 11 |
SLEEP DISORDER THERAPY |
6 |
0.0303 |
| 12 |
APPENDICOLITH |
10 |
0.0258 |
| 13 |
PREMATURE BABY DEATH |
2 |
0.0244 |
| 14 |
FOOD PROTEIN-INDUCED ENTEROCOLITIS SYNDROME |
1 |
0.0238 |
| 15 |
SELENIUM DEFICIENCY |
1 |
0.0238 |
| 16 |
PUNCTURE SITE ERYTHEMA |
2 |
0.0233 |
| 17 |
ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA |
1 |
0.0208 |
| 18 |
PUNCTURE SITE BRUISE |
1 |
0.0196 |
| 19 |
FAT EMBOLISM SYNDROME |
1 |
0.0182 |
| 20 |
CATHETER SITE GRANULOMA |
1 |
0.0175 |
| 21 |
ANTI-MUELLERIAN HORMONE LEVEL DECREASED |
1 |
0.0172 |
| 22 |
CIRCULATORY FAILURE NEONATAL |
1 |
0.0169 |
| 23 |
ADMINISTRATION SITE NODULE |
1 |
0.0167 |
| 24 |
ANTACID THERAPY |
2 |
0.0154 |
| 25 |
BACTEROIDES INFECTION |
4 |
0.0153 |
| 26 |
VENOUS OXYGEN SATURATION DECREASED |
1 |
0.0141 |
| 27 |
ANALGESIC THERAPY |
3 |
0.0093 |
| 28 |
DRUG THERAPY |
3 |
0.0088 |
| 29 |
DISUSE SYNDROME |
1 |
0.0086 |
| 30 |
ROSEOLOVIRUS TEST POSITIVE |
1 |
0.0082 |
| 31 |
CANDIDA ENDOPHTHALMITIS |
1 |
0.0082 |
| 32 |
PSEUDOHYPONATRAEMIA |
1 |
0.0073 |
| 33 |
RETINOPATHY OF PREMATURITY |
4 |
0.0072 |
| 34 |
ANTICOAGULANT THERAPY |
2 |
0.0070 |
| 35 |
TOTAL BILE ACIDS INCREASED |
1 |
0.0068 |
| 36 |
REFEEDING SYNDROME |
1 |
0.0066 |
| 37 |
VASCULAR DEVICE OCCLUSION |
2 |
0.0059 |
| 38 |
BLOOD ZINC DECREASED |
1 |
0.0055 |
| 39 |
CATHETER SITE INDURATION |
1 |
0.0052 |
| 40 |
ABNORMAL CLOTTING FACTOR |
1 |
0.0049 |
| 41 |
PROTEUS TEST POSITIVE |
1 |
0.0045 |
| 42 |
CONGENITAL HIATUS HERNIA |
1 |
0.0044 |
| 43 |
PUNCTURE SITE PAIN |
1 |
0.0043 |
| 44 |
INJECTION SITE PHLEBITIS |
1 |
0.0043 |
| 45 |
GENITAL DISCHARGE |
1 |
0.0042 |
| 46 |
DUODENAL STENOSIS |
2 |
0.0041 |
| 47 |
HYPERPYREXIA |
17 |
0.0040 |
| 48 |
PROCEDURAL INTESTINAL PERFORATION |
1 |
0.0037 |
| 49 |
HYPERPHOSPHATAEMIA |
8 |
0.0037 |
| 50 |
COAGULATION FACTOR DECREASED |
1 |
0.0037 |
| 51 |
LIMBIC ENCEPHALITIS |
1 |
0.0036 |
| 52 |
SUPERFICIAL VEIN THROMBOSIS |
3 |
0.0036 |
| 53 |
PERIVENTRICULAR LEUKOMALACIA |
1 |
0.0035 |
| 54 |
HYPERVISCOSITY SYNDROME |
1 |
0.0035 |
| 55 |
DEVICE COMPUTER ISSUE |
1 |
0.0033 |
| 56 |
DUODENAL OBSTRUCTION |
1 |
0.0033 |
| 57 |
DEVICE RELATED BACTERAEMIA |
1 |
0.0032 |
| 58 |
GASTROENTERITIS RADIATION |
1 |
0.0030 |
| 59 |
BREAST HAEMORRHAGE |
1 |
0.0030 |
| 60 |
BILIRUBIN CONJUGATED INCREASED |
7 |
0.0030 |
| 61 |
BLOOD PHOSPHORUS INCREASED |
8 |
0.0029 |
| 62 |
PNEUMONITIS ASPIRATION |
1 |
0.0029 |
| 63 |
LARGE INTESTINAL ULCER HAEMORRHAGE |
1 |
0.0029 |
| 64 |
DERMATITIS DIAPER |
2 |
0.0028 |
| 65 |
CHRONIC RESPIRATORY DISEASE |
1 |
0.0028 |
| 66 |
IMMUNE-MEDIATED CHOLANGITIS |
1 |
0.0028 |
| 67 |
TRANCE |
1 |
0.0027 |
| 68 |
ANISOCORIA |
1 |
0.0026 |
| 69 |
RADIATION OESOPHAGITIS |
1 |
0.0026 |
| 70 |
SKIN ULCER HAEMORRHAGE |
1 |
0.0026 |
| 71 |
BRONCHOPULMONARY DYSPLASIA |
2 |
0.0025 |
| 72 |
INFANTILE APNOEA |
2 |
0.0025 |
| 73 |
ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL |
1 |
0.0022 |
| 74 |
MENINGOENCEPHALITIS HERPETIC |
1 |
0.0022 |
| 75 |
EPIDERMOLYSIS |
1 |
0.0022 |
| 76 |
VASCULAR PAIN |
2 |
0.0021 |
| 77 |
TUMOUR INVASION |
1 |
0.0021 |
| 78 |
DEVICE RELATED SEPSIS |
4 |
0.0020 |
| 79 |
OESOPHAGEAL ULCER HAEMORRHAGE |
1 |
0.0020 |
| 80 |
FOCAL NODULAR HYPERPLASIA |
1 |
0.0019 |
| 81 |
OCCULT BLOOD |
1 |
0.0019 |
| 82 |
INFUSION SITE VESICLES |
1 |
0.0019 |
| 83 |
IRON DEFICIENCY |
8 |
0.0018 |
| 84 |
PHLEBITIS |
9 |
0.0018 |
| 85 |
LARYNGEAL STENOSIS |
1 |
0.0017 |
| 86 |
CYTOMEGALOVIRUS TEST POSITIVE |
3 |
0.0017 |
| 87 |
INTRAVENTRICULAR HAEMORRHAGE |
4 |
0.0016 |
| 88 |
PSOAS ABSCESS |
1 |
0.0016 |
| 89 |
ANION GAP |
1 |
0.0016 |
| 90 |
PERITONEAL DISORDER |
1 |
0.0015 |
| 91 |
ENTEROCOCCUS TEST POSITIVE |
1 |
0.0015 |
| 92 |
GASTROINTESTINAL MUCOSAL DISORDER |
1 |
0.0015 |
| 93 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
2 |
0.0014 |
| 94 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
1 |
0.0014 |
| 95 |
BLOOD URIC ACID INCREASED |
8 |
0.0014 |
| 96 |
ESCHAR |
1 |
0.0014 |
| 97 |
BILIARY DILATATION |
2 |
0.0014 |
| 98 |
AMINO ACID LEVEL INCREASED |
1 |
0.0013 |
| 99 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
1 |
0.0013 |
| 100 |
STOMA SITE HAEMORRHAGE |
2 |
0.0013 |
| 101 |
METAPNEUMOVIRUS INFECTION |
1 |
0.0013 |
| 102 |
TOTAL LUNG CAPACITY DECREASED |
2 |
0.0013 |
| 103 |
LYMPHOCYTE STIMULATION TEST POSITIVE |
1 |
0.0012 |
| 104 |
ELECTROCARDIOGRAM ST SEGMENT ABNORMAL |
1 |
0.0012 |
| 105 |
ANAL ULCER |
1 |
0.0012 |
| 106 |
HYPOPHOSPHATAEMIA |
9 |
0.0012 |
| 107 |
OESOPHAGEAL PERFORATION |
1 |
0.0012 |
| 108 |
INFUSION SITE OEDEMA |
1 |
0.0012 |
| 109 |
HYPERTRIGLYCERIDAEMIA |
7 |
0.0012 |
| 110 |
HEPATIC HAEMORRHAGE |
1 |
0.0012 |
| 111 |
CHILLS |
134 |
0.0011 |
| 112 |
UPPER AIRWAY OBSTRUCTION |
1 |
0.0011 |
| 113 |
ENTEROCOLITIS INFECTIOUS |
1 |
0.0011 |
| 114 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
1 |
0.0011 |
| 115 |
APPENDICITIS |
10 |
0.0011 |
| 116 |
TEMPERATURE INTOLERANCE |
11 |
0.0011 |
| 117 |
DEVICE RELATED INFECTION |
16 |
0.0010 |
| 118 |
DEVICE RELATED THROMBOSIS |
1 |
0.0010 |
| 119 |
PYURIA |
1 |
0.0010 |
| 120 |
MESENTERIC VEIN THROMBOSIS |
1 |
0.0010 |
| 121 |
IMMUNE-MEDIATED DERMATITIS |
1 |
0.0010 |
| 122 |
MYASTHENIA GRAVIS |
8 |
0.0010 |
| 123 |
TUMOUR NECROSIS |
1 |
0.0009 |
| 124 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
1 |
0.0009 |
| 125 |
AMAUROSIS FUGAX |
1 |
0.0009 |
| 126 |
KLEBSIELLA SEPSIS |
1 |
0.0009 |
| 127 |
VASCULAR DEVICE INFECTION |
4 |
0.0009 |
| 128 |
FOCAL DYSCOGNITIVE SEIZURES |
1 |
0.0009 |
| 129 |
BLOOD FIBRINOGEN DECREASED |
1 |
0.0009 |
| 130 |
RECTAL ULCER |
1 |
0.0009 |
| 131 |
HYPERTENSIVE EMERGENCY |
1 |
0.0008 |
| 132 |
ESCHERICHIA TEST POSITIVE |
1 |
0.0008 |
| 133 |
ENCEPHALITIS VIRAL |
1 |
0.0008 |
| 134 |
VENOOCCLUSIVE LIVER DISEASE |
4 |
0.0008 |
| 135 |
MALIGNANT MELANOMA IN SITU |
1 |
0.0008 |
| 136 |
RECTAL TENESMUS |
1 |
0.0008 |
| 137 |
SYSTEMIC CANDIDA |
2 |
0.0008 |
| 138 |
CANCER PAIN |
2 |
0.0008 |
| 139 |
INFUSION SITE IRRITATION |
1 |
0.0008 |
| 140 |
NON-HODGKIN'S LYMPHOMA |
1 |
0.0008 |
| 141 |
LUNG OPACITY |
2 |
0.0008 |
| 142 |
BRASH SYNDROME |
1 |
0.0007 |
| 143 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 144 |
MENINGITIS BACTERIAL |
1 |
0.0007 |
| 145 |
PANCREATIC ENZYMES INCREASED |
1 |
0.0007 |
| 146 |
INFUSION SITE REACTION |
2 |
0.0007 |
| 147 |
TROPONIN INCREASED |
5 |
0.0007 |
| 148 |
PNEUMONIA PSEUDOMONAL |
1 |
0.0007 |
| 149 |
CALCULUS URINARY |
1 |
0.0006 |
| 150 |
PULMONARY HAEMORRHAGE |
5 |
0.0006 |
| 151 |
GASTROINTESTINAL STOMA COMPLICATION |
1 |
0.0006 |
| 152 |
VENTRICULAR FIBRILLATION |
7 |
0.0006 |
| 153 |
AORTIC VALVE DISEASE |
1 |
0.0006 |
| 154 |
ANTICONVULSANT DRUG LEVEL INCREASED |
1 |
0.0006 |
| 155 |
ASPHYXIA |
5 |
0.0006 |
| 156 |
SEBORRHOEIC DERMATITIS |
1 |
0.0006 |
| 157 |
CORONAVIRUS INFECTION |
4 |
0.0006 |
| 158 |
HYPERNATRAEMIA |
3 |
0.0006 |
| 159 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 160 |
DYSPHORIA |
3 |
0.0006 |
| 161 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
3 |
0.0006 |
| 162 |
SEIZURE LIKE PHENOMENA |
1 |
0.0006 |
| 163 |
REGURGITATION |
2 |
0.0006 |
| 164 |
INJECTION SITE OEDEMA |
1 |
0.0006 |
| 165 |
MILIARIA |
1 |
0.0006 |
| 166 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 167 |
AORTIC STENOSIS |
2 |
0.0006 |
| 168 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 169 |
JUGULAR VEIN THROMBOSIS |
1 |
0.0006 |
| 170 |
LIVER FUNCTION TEST INCREASED |
12 |
0.0006 |
| 171 |
OPPORTUNISTIC INFECTION |
1 |
0.0005 |
| 172 |
GRANULOCYTE COUNT DECREASED |
1 |
0.0005 |
| 173 |
BACTERIAL INFECTION |
10 |
0.0005 |
| 174 |
ENTEROCOLITIS |
3 |
0.0005 |
| 175 |
HEPATIC MASS |
1 |
0.0005 |
| 176 |
TACHYPNOEA |
7 |
0.0005 |
| 177 |
EPIGASTRIC DISCOMFORT |
2 |
0.0005 |
| 178 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 179 |
VITAMIN B12 DEFICIENCY |
2 |
0.0005 |
| 180 |
IMMUNE-MEDIATED HEPATITIS |
1 |
0.0005 |
| 181 |
EXTRAVASATION |
2 |
0.0005 |
| 182 |
ANAPHYLACTOID REACTION |
2 |
0.0005 |
| 183 |
SUBILEUS |
1 |
0.0005 |
| 184 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 185 |
VASCULAR OCCLUSION |
1 |
0.0005 |
| 186 |
SLEEP DEFICIT |
1 |
0.0005 |
| 187 |
INCORRECT DRUG ADMINISTRATION RATE |
2 |
0.0005 |
| 188 |
RADIATION PNEUMONITIS |
1 |
0.0005 |
| 189 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
8 |
0.0005 |
| 190 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
1 |
0.0005 |
| 191 |
LYMPHOCYTOSIS |
1 |
0.0005 |
| 192 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
0.0005 |
| 193 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
1 |
0.0004 |
| 194 |
PSEUDOMEMBRANOUS COLITIS |
1 |
0.0004 |
| 195 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
11 |
0.0004 |
| 196 |
DISTRIBUTIVE SHOCK |
1 |
0.0004 |
| 197 |
KOUNIS SYNDROME |
1 |
0.0004 |
| 198 |
CHEST DISCOMFORT |
45 |
0.0004 |
| 199 |
ESCHERICHIA BACTERAEMIA |
1 |
0.0004 |
| 200 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
12 |
0.0004 |
| 201 |
URINARY HESITATION |
1 |
0.0004 |
| 202 |
CARDIOGENIC SHOCK |
6 |
0.0004 |
| 203 |
PULSE ABNORMAL |
1 |
0.0004 |
| 204 |
LYMPHADENITIS |
1 |
0.0004 |
| 205 |
NEURALGIA |
10 |
0.0004 |
| 206 |
STAPHYLOCOCCAL SEPSIS |
2 |
0.0004 |
| 207 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 208 |
HEPATOSPLENOMEGALY |
1 |
0.0004 |
| 209 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 210 |
MUCORMYCOSIS |
1 |
0.0004 |
| 211 |
PYREXIA |
133 |
0.0004 |
| 212 |
CYANOSIS |
6 |
0.0004 |
| 213 |
BLOOD LACTIC ACID INCREASED |
2 |
0.0004 |
| 214 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 215 |
LIP BLISTER |
1 |
0.0004 |
| 216 |
PLEURITIC PAIN |
1 |
0.0004 |
| 217 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 218 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
1 |
0.0004 |
| 219 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 220 |
HYPERTONIC BLADDER |
1 |
0.0003 |
| 221 |
LIVER FUNCTION TEST ABNORMAL |
10 |
0.0003 |
| 222 |
BODY TEMPERATURE INCREASED |
7 |
0.0003 |
| 223 |
GASTROINTESTINAL NECROSIS |
1 |
0.0003 |
| 224 |
ASCITES |
10 |
0.0003 |
| 225 |
PURPURA |
3 |
0.0003 |
| 226 |
THORACIC VERTEBRAL FRACTURE |
1 |
0.0003 |
| 227 |
HYPERLIPIDAEMIA |
4 |
0.0003 |
| 228 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 229 |
OROPHARYNGEAL DISCOMFORT |
3 |
0.0003 |
| 230 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 231 |
TOXIC EPIDERMAL NECROLYSIS |
5 |
0.0003 |
| 232 |
SWELLING OF EYELID |
2 |
0.0003 |
| 233 |
RESPIRATORY RATE DECREASED |
1 |
0.0003 |
| 234 |
INFUSION SITE SWELLING |
2 |
0.0003 |
| 235 |
HEPATITIS B REACTIVATION |
1 |
0.0003 |
| 236 |
VULVOVAGINAL DRYNESS |
1 |
0.0003 |
| 237 |
RASH GENERALISED |
8 |
0.0003 |
| 238 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 239 |
NEPHRITIS |
1 |
0.0003 |
| 240 |
ABDOMINAL DISTENSION |
31 |
0.0003 |
| 241 |
BLOOD BILIRUBIN INCREASED |
8 |
0.0003 |
| 242 |
HEPATIC FUNCTION ABNORMAL |
11 |
0.0003 |
| 243 |
PALPITATIONS |
34 |
0.0003 |
| 244 |
GRANULOMA |
1 |
0.0003 |
| 245 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 246 |
ERYTHEMA NODOSUM |
1 |
0.0003 |
| 247 |
ASPARTATE AMINOTRANSFERASE INCREASED |
15 |
0.0003 |
| 248 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
| 249 |
METABOLIC ACIDOSIS |
9 |
0.0003 |
| 250 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1 |
0.0003 |
| 251 |
LIVER TRANSPLANT |
1 |
0.0003 |
| 252 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1 |
0.0003 |
| 253 |
AMYLASE INCREASED |
1 |
0.0003 |
| 254 |
STEVENS-JOHNSON SYNDROME |
6 |
0.0003 |
| 255 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 256 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 257 |
THYROID MASS |
1 |
0.0003 |
| 258 |
APNOEA |
2 |
0.0003 |
| 259 |
TESTIS CANCER |
1 |
0.0003 |
| 260 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 261 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 262 |
ULCER |
4 |
0.0003 |
| 263 |
SKIN PAPILLOMA |
1 |
0.0002 |
| 264 |
SHOCK HAEMORRHAGIC |
2 |
0.0002 |
| 265 |
HYPERURICAEMIA |
1 |
0.0002 |
| 266 |
VENTRICULAR TACHYCARDIA |
4 |
0.0002 |
| 267 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 268 |
INFUSION SITE ERYTHEMA |
2 |
0.0002 |
| 269 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 270 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 271 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 272 |
BLOOD CALCIUM INCREASED |
2 |
0.0002 |
| 273 |
GINGIVAL SWELLING |
1 |
0.0002 |
| 274 |
BLOOD TRIGLYCERIDES INCREASED |
4 |
0.0002 |
| 275 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
4 |
0.0002 |
| 276 |
RESPIRATORY RATE INCREASED |
2 |
0.0002 |
| 277 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 278 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 279 |
PALLOR |
6 |
0.0002 |
| 280 |
LUMBAR VERTEBRAL FRACTURE |
1 |
0.0002 |
| 281 |
BLOOD TEST ABNORMAL |
3 |
0.0002 |
| 282 |
DISSEMINATED INTRAVASCULAR COAGULATION |
3 |
0.0002 |
| 283 |
VAGINAL INFECTION |
1 |
0.0002 |
| 284 |
CARDIAC TAMPONADE |
1 |
0.0002 |
| 285 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 286 |
CHOLESTASIS |
4 |
0.0002 |
| 287 |
HYPERCHOLESTEROLAEMIA |
2 |
0.0002 |
| 288 |
THROMBOTIC MICROANGIOPATHY |
2 |
0.0002 |
| 289 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
1 |
0.0002 |
| 290 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 291 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 292 |
PNEUMONIA ASPIRATION |
5 |
0.0002 |
| 293 |
HAEMATEMESIS |
5 |
0.0002 |
| 294 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
1 |
0.0002 |
| 295 |
ENDOCARDITIS |
1 |
0.0002 |
| 296 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 297 |
TRISMUS |
1 |
0.0002 |
| 298 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 299 |
THERAPY PARTIAL RESPONDER |
3 |
0.0002 |
| 300 |
PNEUMOTHORAX |
3 |
0.0002 |
| 301 |
NYSTAGMUS |
1 |
0.0002 |
| 302 |
ANAL ABSCESS |
1 |
0.0002 |
| 303 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 304 |
HYDROCEPHALUS |
1 |
0.0002 |
| 305 |
CHOKING SENSATION |
1 |
0.0002 |
| 306 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 307 |
FEELING COLD |
5 |
0.0002 |
| 308 |
ALANINE AMINOTRANSFERASE INCREASED |
11 |
0.0002 |
| 309 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 310 |
GASTRIC HAEMORRHAGE |
2 |
0.0002 |
| 311 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 312 |
HYPOKALAEMIA |
8 |
0.0002 |
| 313 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
9 |
0.0002 |
| 314 |
RALES |
1 |
0.0002 |
| 315 |
STRESS CARDIOMYOPATHY |
1 |
0.0002 |
| 316 |
LYMPHOCYTE COUNT DECREASED |
3 |
0.0002 |
| 317 |
BACTERAEMIA |
2 |
0.0002 |
| 318 |
GOUT |
3 |
0.0002 |
| 319 |
INFUSION RELATED REACTION |
11 |
0.0002 |
| 320 |
HEPATITIS B |
1 |
0.0002 |
| 321 |
INGUINAL HERNIA |
1 |
0.0002 |
| 322 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 323 |
HYPONATRAEMIA |
9 |
0.0002 |
| 324 |
SCREAMING |
1 |
0.0002 |
| 325 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 326 |
PROCTALGIA |
1 |
0.0002 |
| 327 |
HERPES SIMPLEX |
1 |
0.0002 |
| 328 |
SEPSIS |
17 |
0.0002 |
| 329 |
HYPOGAMMAGLOBULINAEMIA |
1 |
0.0002 |
| 330 |
BLOOD CHOLESTEROL INCREASED |
7 |
0.0002 |
| 331 |
IRRITABILITY |
9 |
0.0001 |
| 332 |
SWELLING |
14 |
0.0001 |
| 333 |
CYTOKINE RELEASE SYNDROME |
3 |
0.0001 |
| 334 |
JAUNDICE |
4 |
0.0001 |
| 335 |
BRONCHIECTASIS |
1 |
0.0001 |
| 336 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 337 |
HYPERHIDROSIS |
19 |
0.0001 |
| 338 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 339 |
CROHN'S DISEASE |
1 |
0.0001 |
| 340 |
ECCHYMOSIS |
1 |
0.0001 |
| 341 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 342 |
FORMICATION |
1 |
0.0001 |
| 343 |
HYPOMAGNESAEMIA |
2 |
0.0001 |
| 344 |
DEVICE OCCLUSION |
2 |
0.0001 |
| 345 |
PAPULE |
1 |
0.0001 |
| 346 |
FEAR OF INJECTION |
1 |
0.0001 |
| 347 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 348 |
PANIC REACTION |
1 |
0.0001 |
| 349 |
GASTROENTERITIS |
2 |
0.0001 |
| 350 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 351 |
HEPATOCELLULAR CARCINOMA |
1 |
0.0001 |
| 352 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 353 |
DIABETES MELLITUS |
10 |
0.0001 |
| 354 |
HYPERTHERMIA |
1 |
0.0001 |
| 355 |
ACIDOSIS |
1 |
0.0001 |
| 356 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 357 |
HAEMOLYSIS |
1 |
0.0001 |
| 358 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 359 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 360 |
ACUTE MYELOID LEUKAEMIA |
2 |
0.0001 |
| 361 |
FLUSHING |
13 |
0.0001 |
| 362 |
SLEEP DISORDER |
9 |
0.0001 |
| 363 |
TORSADE DE POINTES |
1 |
0.0001 |
| 364 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 365 |
ANAPHYLACTIC REACTION |
7 |
0.0001 |
| 366 |
PULMONARY EMBOLISM |
12 |
0.0001 |
| 367 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 368 |
GINGIVAL PAIN |
1 |
0.0001 |
| 369 |
HYPOTHYROIDISM |
4 |
0.0001 |
| 370 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 371 |
HICCUPS |
1 |
0.0001 |
| 372 |
CYTOMEGALOVIRUS INFECTION |
2 |
0.0001 |
| 373 |
COAGULOPATHY |
2 |
0.0001 |
| 374 |
LIVE BIRTH |
1 |
0.0001 |
| 375 |
FACE OEDEMA |
2 |
0.0001 |
| 376 |
INADEQUATE ANALGESIA |
1 |
0.0001 |
| 377 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 378 |
ANAPHYLACTIC SHOCK |
3 |
0.0001 |
| 379 |
DELIRIUM |
4 |
0.0001 |
| 380 |
VOMITING |
54 |
0.0001 |
| 381 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 382 |
TUMOUR LYSIS SYNDROME |
1 |
0.0001 |
| 383 |
COLD SWEAT |
2 |
0.0001 |
| 384 |
LUNG INFILTRATION |
1 |
0.0001 |
| 385 |
CARDIOTOXICITY |
1 |
0.0001 |
| 386 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 387 |
DRY MOUTH |
9 |
0.0001 |
| 388 |
END STAGE RENAL DISEASE |
2 |
0.0001 |
| 389 |
HIDRADENITIS |
1 |
0.0001 |
| 390 |
OVARIAN CANCER |
1 |
0.0001 |
| 391 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 392 |
RENAL DISORDER |
5 |
0.0001 |
| 393 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 394 |
DEFORMITY |
1 |
0.0001 |
| 395 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 396 |
NAUSEA |
83 |
0.0001 |
| 397 |
ATELECTASIS |
1 |
0.0001 |
| 398 |
ERUCTATION |
2 |
0.0001 |
| 399 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 400 |
INTENTIONAL PRODUCT MISUSE |
9 |
0.0001 |
| 401 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 402 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 403 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
4 |
0.0001 |
| 404 |
PRESCRIBED UNDERDOSE |
2 |
0.0001 |
| 405 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
0.0001 |
| 406 |
THROMBOSIS |
8 |
0.0001 |
| 407 |
ABDOMINAL PAIN |
23 |
0.0001 |
| 408 |
TOOTH ABSCESS |
1 |
0.0001 |
| 409 |
NEUTROPHIL COUNT DECREASED |
4 |
0.0001 |
| 410 |
EPILEPSY |
3 |
0.0001 |
| 411 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 412 |
RIB FRACTURE |
2 |
0.0001 |
| 413 |
PERITONITIS |
2 |
0.0001 |
| 414 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 415 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 416 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 417 |
PLATELET COUNT DECREASED |
10 |
0.0001 |
| 418 |
EPISTAXIS |
7 |
0.0001 |
| 419 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 420 |
ASPIRATION |
1 |
0.0001 |
| 421 |
STAPHYLOCOCCAL INFECTION |
3 |
0.0001 |
| 422 |
MELAENA |
2 |
0.0001 |
| 423 |
FEBRILE NEUTROPENIA |
6 |
0.0001 |
| 424 |
BLOOD PRESSURE DECREASED |
6 |
0.0001 |
| 425 |
LIVER DISORDER |
4 |
0.0001 |
| 426 |
MEDICATION ERROR |
5 |
0.0001 |
| 427 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 428 |
PANCYTOPENIA |
5 |
0.0001 |
| 429 |
ORAL PAIN |
2 |
0.0001 |
| 430 |
ANAEMIA |
17 |
0.0001 |
| 431 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 432 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 433 |
OXYGEN SATURATION DECREASED |
5 |
0.0001 |
| 434 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 435 |
MICTURITION URGENCY |
1 |
0.0001 |
| 436 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 437 |
EYELID OEDEMA |
1 |
0.0001 |
| 438 |
SPLENOMEGALY |
1 |
0.0001 |
| 439 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 440 |
RENAL IMPAIRMENT |
7 |
0.0001 |
| 441 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 442 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 443 |
NOCTURIA |
1 |
0.0001 |
| 444 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 445 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 446 |
DISCOMFORT |
5 |
0.0001 |
| 447 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 448 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 449 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 450 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 451 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 452 |
HEART RATE INCREASED |
8 |
0.0001 |
| 453 |
ILEUS |
1 |
0.0001 |
| 454 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 455 |
HYPOPHAGIA |
2 |
0.0001 |
| 456 |
MYDRIASIS |
1 |
0.0001 |
| 457 |
DRUG RESISTANCE |
2 |
0.0001 |
| 458 |
GENERAL PHYSICAL HEALTH DETERIORATION |
9 |
0.0001 |
| 459 |
DYSPNOEA |
44 |
0.0001 |
| 460 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 461 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 462 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 463 |
PNEUMONITIS |
2 |
0.0001 |
| 464 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 465 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 466 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 467 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 468 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 469 |
POLLAKIURIA |
3 |
0.0001 |
| 470 |
HAEMOPTYSIS |
2 |
0.0001 |
| 471 |
MASS |
1 |
0.0001 |
| 472 |
THROMBOCYTOPENIA |
8 |
0.0001 |
| 473 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 474 |
PRURITUS |
27 |
0.0001 |
| 475 |
PARALYSIS |
1 |
0.0001 |
| 476 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 477 |
TACHYCARDIA |
6 |
0.0001 |
| 478 |
PULMONARY MASS |
1 |
0.0001 |
| 479 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 480 |
RASH |
29 |
0.0001 |
| 481 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 482 |
HEPATIC FAILURE |
2 |
0.0001 |
| 483 |
INJECTION SITE SWELLING |
5 |
0.0001 |
| 484 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 485 |
WHITE BLOOD CELL COUNT DECREASED |
7 |
0.0001 |
| 486 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 487 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 488 |
DRUG INTOLERANCE |
6 |
0.0001 |
| 489 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
| 490 |
HYPERTENSION |
13 |
0.0001 |
| 491 |
BLOOD CREATININE INCREASED |
4 |
0.0001 |
| 492 |
SEIZURE |
7 |
0.0001 |
| 493 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 494 |
URINARY RETENTION |
2 |
0.0001 |
| 495 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 496 |
CONSTIPATION |
13 |
0.0001 |
| 497 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 498 |
CANDIDA INFECTION |
1 |
0.0001 |
| 499 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 500 |
PARANOIA |
1 |
0.0001 |
| 501 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 502 |
SPEECH DISORDER |
3 |
0.0001 |
| 503 |
MUSCULOSKELETAL STIFFNESS |
5 |
0.0001 |
| 504 |
HYPOXIA |
2 |
0.0001 |
| 505 |
DRUG ERUPTION |
1 |
0.0001 |
| 506 |
INJECTION SITE ERYTHEMA |
7 |
0.0001 |
| 507 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
4 |
0.0001 |
| 508 |
DIZZINESS |
28 |
0.0001 |
| 509 |
THIRST |
1 |
0.0001 |
| 510 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 511 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 512 |
MYELOSUPPRESSION |
2 |
0.0001 |
| 513 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 514 |
OEDEMA |
3 |
0.0001 |
| 515 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 516 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 517 |
UNDERDOSE |
4 |
0.0001 |
| 518 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 519 |
SOMNOLENCE |
11 |
0.0001 |
| 520 |
AGITATION |
4 |
0.0001 |
| 521 |
TREMOR |
9 |
0.0001 |
| 522 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 523 |
ABDOMINAL DISCOMFORT |
9 |
0.0001 |
| 524 |
BLISTER |
3 |
0.0001 |
| 525 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 526 |
PHOTOPHOBIA |
1 |
0.0001 |
| 527 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 528 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 529 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 530 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 531 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 532 |
EAR PAIN |
1 |
0.0001 |
| 533 |
OVERDOSE |
11 |
0.0001 |
| 534 |
WHEEZING |
3 |
0.0001 |
| 535 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 536 |
CARDIAC FAILURE |
4 |
0.0000 |
| 537 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 538 |
STOMATITIS |
3 |
0.0000 |
| 539 |
TASTE DISORDER |
1 |
0.0000 |
| 540 |
DEVICE BREAKAGE |
2 |
0.0000 |
| 541 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 542 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 543 |
CARDIAC ARREST |
4 |
0.0000 |
| 544 |
DERMATITIS |
1 |
0.0000 |
| 545 |
JOINT INJURY |
1 |
0.0000 |
| 546 |
INTENTIONAL OVERDOSE |
3 |
0.0000 |
| 547 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 548 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 549 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 550 |
CONDITION AGGRAVATED |
14 |
0.0000 |
| 551 |
SEPTIC SHOCK |
2 |
0.0000 |
| 552 |
BLOOD PRESSURE INCREASED |
7 |
0.0000 |
| 553 |
HEPATOTOXICITY |
1 |
0.0000 |
| 554 |
HYPOTENSION |
9 |
0.0000 |
| 555 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 556 |
RASH PAPULAR |
1 |
0.0000 |
| 557 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 558 |
LOWER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 559 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 560 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 561 |
INJECTION SITE PAIN |
13 |
0.0000 |
| 562 |
ARRHYTHMIA |
2 |
0.0000 |
| 563 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 564 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 565 |
ATRIAL FIBRILLATION |
4 |
0.0000 |
| 566 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 567 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 568 |
LUNG DISORDER |
2 |
0.0000 |
| 569 |
LIVER INJURY |
1 |
0.0000 |
| 570 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 571 |
PNEUMONIA |
13 |
0.0000 |
| 572 |
HYPOAESTHESIA |
6 |
0.0000 |
| 573 |
AGGRESSION |
2 |
0.0000 |
| 574 |
CELLULITIS |
2 |
0.0000 |
| 575 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 576 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 577 |
HEPATITIS |
1 |
0.0000 |
| 578 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 579 |
ERYTHEMA |
8 |
0.0000 |
| 580 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 581 |
DEAFNESS |
1 |
0.0000 |
| 582 |
PANCREATITIS |
2 |
0.0000 |
| 583 |
BRADYCARDIA |
2 |
0.0000 |
| 584 |
EAR INFECTION |
1 |
0.0000 |
| 585 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 586 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 587 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 588 |
NECK PAIN |
2 |
0.0000 |
| 589 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 590 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 591 |
ANGINA PECTORIS |
1 |
0.0000 |
| 592 |
DECREASED APPETITE |
8 |
0.0000 |
| 593 |
BACK PAIN |
8 |
0.0000 |
| 594 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 595 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 596 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 597 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 598 |
FEELING HOT |
2 |
0.0000 |
| 599 |
INJECTION SITE RASH |
1 |
0.0000 |
| 600 |
GYNAECOMASTIA |
1 |
0.0000 |
| 601 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 602 |
PRODUCT USE IN UNAPPROVED INDICATION |
8 |
0.0000 |
| 603 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 604 |
ASTHENIA |
12 |
0.0000 |
| 605 |
CYSTITIS |
1 |
0.0000 |
| 606 |
NIGHT SWEATS |
1 |
0.0000 |
| 607 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 608 |
CHOLELITHIASIS |
1 |
0.0000 |
| 609 |
DYSPEPSIA |
3 |
0.0000 |
| 610 |
OSTEONECROSIS |
1 |
0.0000 |
| 611 |
LIP SWELLING |
1 |
0.0000 |
| 612 |
FUNGAL INFECTION |
1 |
0.0000 |
| 613 |
SKIN DISORDER |
1 |
0.0000 |
| 614 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 615 |
INJECTION SITE REACTION |
2 |
0.0000 |
| 616 |
NIGHTMARE |
1 |
0.0000 |
| 617 |
HYPERKALAEMIA |
1 |
0.0000 |
| 618 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 619 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 620 |
RESTLESSNESS |
1 |
0.0000 |
| 621 |
DYSURIA |
1 |
0.0000 |
| 622 |
CHEST PAIN |
5 |
0.0000 |
| 623 |
DYSGEUSIA |
2 |
0.0000 |
| 624 |
DYSARTHRIA |
1 |
0.0000 |
| 625 |
ASTHMA |
3 |
0.0000 |
| 626 |
COLITIS |
1 |
0.0000 |
| 627 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 628 |
DISEASE PROGRESSION |
3 |
0.0000 |
| 629 |
DISORIENTATION |
1 |
0.0000 |
| 630 |
OFF LABEL USE |
22 |
0.0000 |
| 631 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 632 |
DYSKINESIA |
1 |
0.0000 |
| 633 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 634 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 635 |
MYALGIA |
4 |
0.0000 |
| 636 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 637 |
MENTAL DISORDER |
1 |
0.0000 |
| 638 |
ANGIOEDEMA |
1 |
0.0000 |
| 639 |
DEHYDRATION |
3 |
0.0000 |
| 640 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 641 |
HEADACHE |
14 |
0.0000 |
| 642 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 643 |
NEUTROPENIA |
3 |
0.0000 |
| 644 |
SKIN IRRITATION |
1 |
0.0000 |
| 645 |
TINNITUS |
1 |
0.0000 |
| 646 |
ADVERSE EVENT |
2 |
0.0000 |
| 647 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 648 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 649 |
INFECTION |
3 |
0.0000 |
| 650 |
DRY EYE |
1 |
0.0000 |
| 651 |
FLUID RETENTION |
1 |
0.0000 |
| 652 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 653 |
THERAPY CESSATION |
1 |
0.0000 |
| 654 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 655 |
HAEMORRHAGE |
2 |
0.0000 |
| 656 |
DIARRHOEA |
12 |
0.0000 |
| 657 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 658 |
RASH PRURITIC |
1 |
0.0000 |
| 659 |
MALAISE |
8 |
0.0000 |
| 660 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 661 |
INFLUENZA |
2 |
0.0000 |
| 662 |
URTICARIA |
3 |
0.0000 |
| 663 |
FLATULENCE |
1 |
0.0000 |
| 664 |
CONVULSION |
1 |
0.0000 |
| 665 |
LETHARGY |
1 |
0.0000 |
| 666 |
BONE PAIN |
1 |
0.0000 |
| 667 |
SURGERY |
1 |
0.0000 |
| 668 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 669 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 670 |
RHINORRHOEA |
1 |
0.0000 |
| 671 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 672 |
AMNESIA |
1 |
0.0000 |
| 673 |
SWELLING FACE |
1 |
0.0000 |
| 674 |
DRY SKIN |
2 |
0.0000 |
| 675 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 676 |
PAIN |
9 |
0.0000 |
| 677 |
COUGH |
4 |
0.0000 |
| 678 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 679 |
BRONCHITIS |
1 |
0.0000 |
| 680 |
HALLUCINATION |
1 |
0.0000 |
| 681 |
HOT FLUSH |
1 |
0.0000 |
| 682 |
DRUG INTERACTION |
2 |
0.0000 |
| 683 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 684 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 685 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 686 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 687 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 688 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 689 |
COVID-19 |
2 |
0.0000 |
| 690 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 691 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 692 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 693 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 694 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 695 |
DYSPHAGIA |
1 |
0.0000 |
| 696 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 697 |
DEATH |
9 |
0.0000 |
| 698 |
SYNCOPE |
1 |
0.0000 |
| 699 |
SINUSITIS |
1 |
0.0000 |
| 700 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 701 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 702 |
DRUG INEFFECTIVE |
12 |
0.0000 |
| 703 |
WEIGHT INCREASED |
2 |
0.0000 |
| 704 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 705 |
RENAL FAILURE |
1 |
0.0000 |
| 706 |
ARTHRALGIA |
3 |
0.0000 |
| 707 |
WEIGHT DECREASED |
2 |
0.0000 |
| 708 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 709 |
PARAESTHESIA |
1 |
0.0000 |
| 710 |
FALL |
2 |
0.0000 |
| 711 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 712 |
MUSCLE SPASMS |
1 |
0.0000 |
| 713 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 714 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 715 |
ALOPECIA |
1 |
0.0000 |
| 716 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 717 |
DEPRESSION |
1 |
0.0000 |
| 718 |
FEELING ABNORMAL |
1 |
0.0000 |
| 719 |
FATIGUE |
3 |
0.0000 |
| 720 |
INSOMNIA |
1 |
0.0000 |